[1]
Hansen, M.; Kilk, K.; Langel, Ü. Predicting cell-penetrating peptides. Adv. Drug Deliver. Rev.NI, 2008, 60, 572-579.
[2]
Green, M.; Paul, M.L. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell, 1988, 55-, 1179, 1188.
[3]
Frankel, A.D.; Pabo, C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell, 1988, 55(6), 1189-1193.
[4]
Joliot, A.; Pernelle, C.; Deagostini-Bazin, H.; Prochiantz, A. Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl. Acad. Sci. USA, 1991, 88, 1864-1868.
[5]
Derossi, D.; Joliot, A.H.; Chassaing, G.; Prochiantz, A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem., 1994, 269, 10444-10450.
[6]
Eiríksdóttir, E.; Konate, K.; Langel, U.; Divita, G.; Deshayes, S. Secondary structure of cell-penetrating peptides controls membrane interaction and insertion. Biochim. Biophys. Acta, 2010, 1798, 1119-1128.
[7]
Elmquist, A.; Hansen, M.; Langel, U. Structure-activity relationship study of the cell-penetrating peptide pVEC. Biochim. Biophys. Acta, 2006, 1758, 721-729.
[8]
Kamide, K.; Nakakubo, H.; Uno, S.; Fukamizu, A. Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications. Int. J. Mol. Med., 2010, 25, 41-51.
[9]
Morris, M.C.; Depollier, J.; Mery, J.; Heitz, F.; Divita, G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol., 2001, 19, 1173-1176.
[10]
Vasconcelos, L.; Parn, K.; Langel, U. Therapeutic potential of cell-penetrating peptides. Ther. Deliv., 2013, 4, 573-591.
[11]
Guidotti, G.; Brambilla, L.; Rossi, D. Cell-Penetrating peptides: From basic research to clinics. Trends Pharmacol. Sci., 2017, 38, 406-424.
[12]
Agrawal, P.; Bhalla, S.; Usmani, S.S.; Singh, S.; Chaudhary, K.; Raghava, G.P.; Gautam, A. CPPsite 2.0: A repository of experimentally validated cell penetrating peptides. Nucleic Acids Res., 2016, 44, D1098-D1103.
[13]
Gautam, A.; Singh, H.; Tyagi, A.; Chaudhary, K.; Kumar, R.; Kapoor, P.; Raghava, G.P. CPPsite: A curated database of cell penetrating peptides. Database, 2012, 1-7.
[14]
Kristensen, M.; Birch, D.; Mørck, N.H. Applications and challenges for use of cell-penetrating peptides as delivery vectors for peptide and protein cargos. Int. J. Mol. Sci., 2016, 17, 1-17.
[15]
Christian, S.; Pilch, J.; Akerman, M.E.; Porkka, K.; Laakkonen, P.; Ruoslahti, E. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J. Cell Biol., 2003, 163, 871-878.
[16]
Borrelli, A.; Tornesello, A.L.; Tornesello, M.L.; Buonaguro, F.M. cell penetrating peptides as molecular carriers for anti-cancer agents. Molecules, 2018, 23, 1-28.
[17]
Copolovici, D.M.; Langel, K.; Eriste, E.; Langel, Ü. Cell-penetrating peptides: Design, synthesis, and applications. ACS Nano, 2014, 8, 1972-1994.
[18]
Stewart, K.M.; Horton, K.L.; Kelley, S.O. Cell-penetrating peptides as delivery vehicles for biology and medicine. ChemInform, 2008, 39, 2242-2255.
[19]
Perillo, E.; Allard-Vannier, E.; Falanga, A.; Stiuso, P.; Vitiello, M.T.; Galdiero, M.; Galdiero, S.; Chourpa, I. Quantitative and qualitative effect of gH625 on the nanoliposome-mediated delivery of mitoxantrone anticancer drug to HeLa cells. Int. J. Pharm., 2015, 488, 59-66.
[20]
Peng, L.H.; Niu, J.; Zhang, C.Z.; Yu, W.; Wu, J.H.; Shan, Y.H.; Wang, X.R.; Shen, Y.Q.; Mao, Z.W.; Liang, W.Q.; Gao, J.Q. TAT conjugated cationic noble metal nanoparticles for gene delivery to epidermal stem cells. Biomaterials, 2014, 35, 5605-5618.
[21]
Gros, E.; Deshayes, S.; Morris, M.C.; Aldrian-Herrada, G.; Depollier, J.; Heitz, F.; Divita, G. A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction. Biochim. Biophys. Acta, 2006, 1758, 384-393.
[22]
Elmquist, A.; Hansen, M.; Langel, U. Structure-activity relationship study of the cell-penetrating peptide pVEC. Biochim. Biophys. Acta, 2006, 1758, 721-729.
[23]
Pooga, M.; Langel, Ü. Classes of cell-penetrating peptides. Methods Mol. Biol., 2015, 1324, 3-28.
[24]
Sandberg, M.; Eriksson, L.; Jonsson, J.; Sjöström, M.; Wold, S. New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. J. Med. Chem., 1998, 41, 2481-2491.
[25]
Thompson, J.D.; Higgins, D.G.; Gibson, T.J. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res., 1994, 22, 4673-4680.
[26]
Karelson, M.; Dobchev, D. Using artificial neural networks to predict cell-penetrating compounds. Expert Opin. Drug Discov., 2011, 6, 783-796.
[27]
Dobchev, D.A.; Mager, I.; Tulp, I.; Karelson, G.; Tamm, T.; Tamm, K.; Janes, J.; Langel, U.; Karelson, M. Prediction of cell-penetrating peptides using artificial neural networks. Curr. Comput. Aided Drug Des., 2010, 6, 79-89.
[28]
Kalafatovic, D.; Giralt, E. Cell-Penetrating peptides: Design strategies beyond primary structure and amphipathicity. Molecules, 2017, 22, 1-38.
[29]
Nakariyakul, S.; Liu, Z.P.; Chen, L. A sequence-based computational approach to predicting PDZ domain- peptide interactions. Biochim. Biophys. Acta, 2014, 1844(1 Pt B), 165-170.
77
6
1